Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Replimune Group, Inc. (REPL)

Biohaven Ltd. and Replimune Group, Inc. are both Biotechnology companies. Biohaven Ltd. and Replimune Group, Inc. are of similar size ($2.3B and $2.2B). Across the 9 metrics below, Replimune Group, Inc. leads on 5 and Biohaven Ltd. on 4.

Valuation

Metric BHVN REPL Biotechnology median
P/E n/m n/m 11.58
P/S 2.30 n/m 9.61
P/B n/m 11.24 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 2.40 n/m 9.43
Earnings yield (25.43%) (12.77%) (32.28%)
Free cash flow yield (21.52%) (10.68%) (22.27%)

Profitability

Metric BHVN REPL Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 940.46% (115.80%) (50.30%)
Return on assets (161.32%) (71.01%) (45.47%)
Return on invested capital (6,659.91%) (928.27%) 0.00%

Growth

Metric BHVN REPL Biotechnology median
Revenue growth (TTM) 425.20% — 6.78%
EPS growth (last fiscal year) 26.08% (10.10%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN REPL Biotechnology median
Debt to equity (2.69) 0.59 0.00
Current ratio 3.05 7.11 4.74
Net debt to EBITDA 0.11 0.51 1.01

Dividend

Metric BHVN REPL Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric BHVN REPL Biotechnology median
Market cap 2.28b 2.21b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack